AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
30 Mar 2012 04:00 PM
RNS
Director/PDMR Shareholding
30 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
30 Mar 2012 07:00 AM
RNS
US Court Finds Seroquel XR Patent Valid
29 Mar 2012 05:00 PM
RNS
Director/PDMR Shareholding
29 Mar 2012 07:00 AM
RNS
Filing of Annual Report on Form 20-F with SEC
29 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
28 Mar 2012 05:00 PM
RNS
Director/PDMR Shareholding
28 Mar 2012 05:00 PM
RNS
Director/PDMR Shareholding
28 Mar 2012 05:00 PM
RNS
Director/PDMR Shareholding
28 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
27 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
26 Mar 2012 11:40 AM
RNS
Annual Financial Report
26 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
26 Mar 2012 07:00 AM
RNS
US Court dismisses lawsuit against the FDA
23 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
22 Mar 2012 10:25 AM
RNS
UK Court finds Seroquel XR patent invalid
22 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
21 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
20 Mar 2012 07:00 AM
RNS
TC-5214 Phase III studies do not meet endpoint
20 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
19 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
16 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
15 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
14 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
13 Mar 2012 07:00 AM
RNS
Files lawsuit against FDA decision on quetiapine
13 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
12 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
09 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
08 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
07 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
06 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
02 Mar 2012 02:00 PM
RNS
Share Repurchase Programme
02 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
01 Mar 2012 04:00 PM
RNS
Total Voting Rights
01 Mar 2012 07:00 AM
RNS
Announces Non-Executive and Chairman changes
29 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
28 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
28 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
28 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
28 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
27 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
27 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
27 Feb 2012 05:30 PM
RNS
Director/PDMR Shareholding
27 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
24 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
23 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
22 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
21 Feb 2012 08:00 AM
RNS
EU approves Caprelsa for thyroid cancer
21 Feb 2012 07:00 AM
RNS
Transaction in Own Shares
20 Feb 2012 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings